No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use
-
Clozapine / adverse effects
-
Clozapine / therapeutic use
-
Diabetes Mellitus, Type 2 / complications*
-
Female
-
Glucagon-Like Peptide 1 / analogs & derivatives*
-
Glucagon-Like Peptide 1 / therapeutic use
-
Glucagon-Like Peptide-1 Receptor
-
Glycated Hemoglobin / analysis
-
Humans
-
Liraglutide
-
Middle Aged
-
Obesity / chemically induced*
-
Obesity / complications
-
Receptors, Glucagon / agonists*
-
Schizophrenia / complications*
-
Schizophrenia / drug therapy
-
Weight Loss / drug effects*
Substances
-
Antipsychotic Agents
-
GLP1R protein, human
-
Glucagon-Like Peptide-1 Receptor
-
Glycated Hemoglobin A
-
Receptors, Glucagon
-
hemoglobin A1c protein, human
-
Liraglutide
-
Glucagon-Like Peptide 1
-
Clozapine